Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ibrutinib 140 MG Oral Capsule

Known as: IBRUTINIB 140MG CAP,ORAL, IBRUTINIB 140MG CAP,ORAL [VA Product], IBRUTINIB 140MG ORAL CAP 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Ibrutinib (Imbruvica), an oral tyrosine kinase inhibitor (TKI) approved for treatment of B-cell malignancies, irreversibly… Expand
Is this relevant?
2016
2016
A validated simple, fast and sensitive bio-analytical assay for ibrutinib and its dihydrodiol metabolite in human and mouse… Expand
Is this relevant?